Prostate News and Research

RSS

Landmark study finds how often cancer patients develop osteonecrosis of the jaw

A landmark study by researchers from the SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute, part of the National Institutes of Health, has found that 2.8 percent of patients on average develop osteonecrosis of the jaw, or ONJ, within three years of starting a common treatment for cancer that has spread to the bone.

17 Dec 2020

No added risks to radiation therapy for cancer patients with COVID-19, says study

A team of radiation oncologists at the Zucker School of Medicine at Hofstra/Northwell in the United States aimed to determine if COVID-19 infected cancer patients receiving radiation therapy (RT) have any different outcome than non-infected patients.

17 Dec 2020

RedHill Biopharma announces promising preliminary results from opaganib study

TEL AVIV, Israel and RALEIGH, NC, December 15, 2020, RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study with opaganib.

15 Dec 2020

Genomic and immune indicators can help identify prostate cancer patients at high risk of lethal outcomes

Prostate cancer is one of the most common cancers among men in the United States. One in nine men will be diagnosed during his lifetime.

15 Dec 2020

Scientist pinpoints genes that promote the growth of prostate cancer cells

Research by a University of Georgia scientist sheds light on how two genes factor into prostate cancer cells becoming resistant to treatment, providing a potential new target for therapeutics.

11 Dec 2020

Cancer Research UK announces dramatic cuts to its life-saving research budget

Cancer Research UK have announced today further dramatic cuts, slashing £45 million from its research budget.

10 Dec 2020

Glyphosate could be used as biomarkers to predict multiple diseases in future generations

Exposure to the widely used weed-killer glyphosate makes genetic changes to rats that can be linked to increased disease in their grandchildren and great-grandchildren, a new study has found.

10 Dec 2020

New guidelines and standards for the treatment of brain tumor complications

The brain can be affected by a number of different types of tumor and this leads to serious complications such as epileptic attacks, brain edema, hemorrhage, or thrombosis.

9 Dec 2020

Evolutionary gene mutation unique to humans may be to blame for risk of advanced cancers

Compared to chimpanzees, our closest evolutionary cousins, humans are particularly prone to developing advanced carcinomas -- the type of tumors that include prostate, breast, lung and colorectal cancers -- even in the absence of known risk factors, such as genetic predisposition or tobacco use.

9 Dec 2020

Study reveals human-specific link between advanced carcinomas and a unique gene

Humans are more prone to develop carcinomas compared with our closest evolutionary cousins, the great apes.

9 Dec 2020

Study findings can guide personalized breast cancer therapies based on melatonin

A Brazilian study published in the Journal of Pineal Research describes a group of genes potentially regulated by the hormone melatonin in some types of cancer, especially breast cancer.

8 Dec 2020

Study assesses different pipelines for timing mutations in cancer genomes

UCLA Jonsson Comprehensive Cancer Center researchers studying cancer evolution have created a framework to help determine which tool combinations are best for pinpointing the exact timing of DNA mutations in cancer genomes.

7 Dec 2020

Study: Tumors with high TMB tend to respond better to immune checkpoint inhibitors

Treatments that harness the immune system to fight cancer have greatly improved outcomes for some people with cancer. Scientists are learning more about why some people respond much better than others to these drugs.

2 Dec 2020

Cancer cells exhibit metabolic changes that make them vulnerable to ferroptosis

If there is a silver lining in cancer's chaotic biology, it's that the same traits that give cancer cells a growth advantage often present opportunities for sabotaging them.

2 Dec 2020

UCLA, UCSF obtain FDA approval for PSMA PET imaging in men with prostate cancer

The University of California's two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.

2 Dec 2020

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

1 Dec 2020

Experimental drug can reverse age-related memory decline in mice

Just a few doses of an experimental drug can reverse age-related declines in memory and mental flexibility in mice, according to a new study by UC San Francisco scientists.

1 Dec 2020

Cost of prostate cancer treatment can be a major source of stress for men, their families

For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

1 Dec 2020

Researchers find substantial regional variation in use of genomic testing for prostate cancer

Gene-expression testing provides better estimates of cancer aggressiveness and assist in treatment decision making for men with prostate cancer.

30 Nov 2020

World’s largest proteomics centre accelerates biomarker discoveries to improve people’s lives

Opened in 2016, Manchester’s Stoller Biomarker Discovery Centre (SBDC) is a globally renowned, multi-million-pound precision medicine research facility.

From Stoller Biomarker Discovery Centre 30 Nov 2020

Prostate News and Research

Landmark study finds how often cancer patients develop osteonecrosis of the jaw

No added risks to radiation therapy for cancer patients with COVID-19, says study

RedHill Biopharma announces promising preliminary results from opaganib study

Genomic and immune indicators can help identify prostate cancer patients at high risk of lethal outcomes

Scientist pinpoints genes that promote the growth of prostate cancer cells

Cancer Research UK announces dramatic cuts to its life-saving research budget

Glyphosate could be used as biomarkers to predict multiple diseases in future generations

New guidelines and standards for the treatment of brain tumor complications

Evolutionary gene mutation unique to humans may be to blame for risk of advanced cancers

Study reveals human-specific link between advanced carcinomas and a unique gene

Study findings can guide personalized breast cancer therapies based on melatonin

Study assesses different pipelines for timing mutations in cancer genomes

Study: Tumors with high TMB tend to respond better to immune checkpoint inhibitors

Cancer cells exhibit metabolic changes that make them vulnerable to ferroptosis

UCLA, UCSF obtain FDA approval for PSMA PET imaging in men with prostate cancer

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Experimental drug can reverse age-related memory decline in mice

Cost of prostate cancer treatment can be a major source of stress for men, their families

Researchers find substantial regional variation in use of genomic testing for prostate cancer

World’s largest proteomics centre accelerates biomarker discoveries to improve people’s lives

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News